As shown in Figure 9C, the combination of Atezolizumab with OX-40_2, OX-40_3 or OX-40_5 exhibits stronger effects, in comparison with single mAbs treatments also in co-cultures with tumor cells, in line with the previous results shown on non-fractionated lymphocytes. The gene discussed is HCRT; the disease is neoplasm.